在喘中改善肺功能,使用半乙烯-白三烯受体抗剂
1Department of Thoracic Medicine, London Chest Hospital, UK.
Lancet (London, England)
|May 4, 1991
概括
该研究发现,ICI 204,219通过阻断cysteinyl-leukotriene受体,显著改善了喘患者的肺功能. 这表明白血素有助于慢性喘中持续的支气管收缩.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性喘的特点是持续的支气管收缩.
- 乙氨基基被认为是喘病理生理学的调解者.
研究的目的:
- 评估ICI 204,219的疗效,一种氨酸-氨酸受体对抗剂,改善慢性喘患者的肺功能.
- 为了确定cysteinyl-leukotrienes是否有助于持续的支气管收缩.
主要方法:
- 这是一项双盲,安慰剂控制的研究,涉及10名肺功能受损的喘患者.
- 患者在随机交叉设计中接受ICI 204,219 (40毫克口服) 和安慰剂.
- 通过从基线测量强迫呼气体积在1秒内 (FEV1) 的增加来评估肺功能.
主要成果:
- 与安慰剂相比,ICI 204,219的使用导致FEV1的显著增加.
- ICI 204,219的支气管扩张作用即使在注射了雾化沙布塔摩尔后也保持不变.
- 没有报告任何重大不良事件.
结论:
- 与ICI 204,219相结合的氨酸-氨酸基因受体对抗作用有效地改善了喘患者的肺功能.
- 这些结果强烈地表明,氨基氨基在导致慢性喘中持续性支气管收缩方面发挥着重要作用.
- ICI 204,219代表了通过向白血三烯通路来管理慢性喘的潜在治疗策略.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Chest Physiotherapy
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


